
Sign up to save your podcasts
Or


In this special 15 minute episode of Magellan In The Know, Portfolio Manager Nikki Thomas is joined by Investment Analyst Wilson Nghe, providing an update on GLP-1 following our recent episode on the weight loss wonder drug. Recently returned from the US, Wilson spoke with commercial players and policy makers on how they will approach reimbursements, which could be one of the biggest drivers to accelerate demand. They also discuss the future of care delivery in the US healthcare system.
Listen below to the full episode
Ep. 40 The weight loss drug shaping-up as a gamechanger
By Magellan Asset Management5
22 ratings
In this special 15 minute episode of Magellan In The Know, Portfolio Manager Nikki Thomas is joined by Investment Analyst Wilson Nghe, providing an update on GLP-1 following our recent episode on the weight loss wonder drug. Recently returned from the US, Wilson spoke with commercial players and policy makers on how they will approach reimbursements, which could be one of the biggest drivers to accelerate demand. They also discuss the future of care delivery in the US healthcare system.
Listen below to the full episode
Ep. 40 The weight loss drug shaping-up as a gamechanger

11 Listeners

85 Listeners

23 Listeners

45 Listeners

9 Listeners

10 Listeners

55 Listeners

21 Listeners

3 Listeners

7 Listeners

26 Listeners

29 Listeners

5 Listeners

19 Listeners

16 Listeners